Sažetak
Purpose: The aim of this study was to figure out the predictive value of inflammatory-linked factors on the efficacy of dexamethasone adjuvant therapy for refractory suppurative meningitis in children.
Methods: Using regression analysis method, 38 children with refractory purulent meningitis, 40 children with purulent meningitis, and 40 healthy children who came to Qingtian County People's Hospital of Lishui City for physical examination during the same period were selected as the research objects, and assigned into the experimental, the control and the healthy groups. The inflammation-linked factors in the three groups were compared, and multivariate Logisitic regression was applied to analyze the predictive indicators and predictive efficacy of dexamethasone treatment in children with refractory suppurative meningitis.
Results: CRP, TNF-α, IL-6, PCT and IL-1β were higher in the study group vs. the control and the healthy, and in the control vs. the healthy (P < 0.05). Multivariate Logisitic regression analysis clarified the predictors of the efficacy of dexamethasone treatment in children with refractory suppurative meningitis were CRP, TNF-α, IL-6, PCT, and IL-1β, which all had good predictive performance, and among which CRP and IL-1β had better predictive performance.
Conclusion: Inflammatory-linked factors have a certain predictive value for the efficacy of dexamethasone adjuvant therapy for refractory suppurative meningitis in children.
Ključne reči
Array
Array
Reference
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.